pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 1
    JMKX-1899
    Colorectal Cancer HUYA Bioscience International LLC
  • Phase 3
    JNJ-1900
    Head And Neck Squamous Cell Carcinoma (HNSC)$JNJ JOHNSON & JOHNSON
  • Phase 2
    JNJ-2056
    Alzheimer's Disease Johnson & Johnson Innovative Medicine
  • Phase 3
← prev
page 99 of 231
next →
131
Pain89
Neurology1
JNJ-69968054
Escherichia coli Infections
$JNJ JOHNSON & JOHNSON
  • Phase 2
    JNS-101
    Friedreich Ataxia$JUNS JUPITER NEUROSCIENCES, INC.
  • Phase 1
    JNS-107
    MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic A…$JUNS JUPITER NEUROSCIENCES, INC.
  • Preclinical
    JNS-108
    Mild Cognitive Impairment$JUNS JUPITER NEUROSCIENCES, INC.
  • Phase 1
    JNS-115
    Parkinson's Disease$JUNS JUPITER NEUROSCIENCES, INC.
  • JOYEAUX
    JOYEAUX (LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)
    no indication XIROMED
  • Phase 1
    JPH-034
    Glioma J-Pharma Co Ltd
  • Preclinical
    JR-220
    Alcohol Use Disorder (AUD) Naprogenix Inc
  • Preclinical
    JV-MD2 (Omega-3)
    Retinopathy Of Prematurity Jenivision Inc (Inactive)
  • Phase 2
    JWATM-204
    Hepatocellular Carcinoma Eureka Therapeutics Inc
  • Phase 1
    JZP-3507
    Ependymoma$JAZZ Jazz Pharmaceuticals plc
  • Phase 1
    JZP-898
    Gastroesophageal (GE) Junction Carcinomas$JAZZ Jazz Pharmaceuticals plc
  • Phase 2
    JadiCell ARDS
    Acute Respiratory Distress Syndrome Breathe Biologics Inc
  • Phase 2
    Jankistomig
    Solid Tumor Ottimo Pharma Ltd
  • Phase 3
    JointStem
    Osteoarthritis Biostar Stem Cell Research Institute
  • Phase 3
    Jynneos
    Jynneos
    Smallpox Bavarian Nordic AS
  • Preclinical
    K-130
    Neurogenic Orthostatic Hypotension (nOH)$AMRX Amneal Pharmaceuticals, Inc.
  • Phase 3
    K-161
    Keratoconjunctivitis Sicca (Dry Eye) Kowa Co Ltd
  • Phase 1
    KA-34
    Osteoarthritis California Institute for Biomedical Research
  • KANJINTI
    KANJINTI (TRASTUZUMAB-ANNS)
    no indication$AMGN AMGEN INC
  • Phase 1
    KB-407
    Cystic Fibrosis$KRYS Krystal Biotech, Inc.
  • Phase 1
    KB-408
    Alpha-1 Antitrypsin Deficiency (A1AD)$KRYS Krystal Biotech, Inc.
  • Phase 2
    KB-707
    Metastatic Melanoma$KRYS Krystal Biotech, Inc.
  • Phase 2
    KB-801
    Neurotrophic Keratitis$KRYS Krystal Biotech, Inc.
  • Phase 2
    KBLP-001
    Plaque Psoriasis (Psoriasis Vulgaris) KoBioLabs Inc
  • Phase 1
    KBLP-002
    Asthma KoBioLabs Inc
  • Preclinical
    KBX-114
    Gynecological Cancer Kaida BioPharma Inc